cytarabine and Ataxia

cytarabine has been researched along with Ataxia in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (46.15)	18.7374
1990's	1 (7.69)	18.2507
2000's	3 (23.08)	29.6817
2010's	2 (15.38)	24.3611
2020's	1 (7.69)	2.80

Authors

Authors	Studies
Ijiro, T; Kiguchi, S; Yaguchi, A; Yokoyama, A	1
Beppu, H; Mizutani, K; Nagao, S; Orand, A; Sonoda, S; Suzuki, S; Takahashi, H; Takayanagi, N; Tomita, Y	1
Berendse, HW; Janssen, JJ; Merle, PA; Ossenkoppele, GJ; Schuurhuis, GJ	1
Cho, SR; Im, SH; Kim, GW; Kim, HO; Lee, JE; Park, CI; Park, ES; Park, KI; Yu, JH	1
Atlas, SW; Bollen, AW; Green, AJ; Langer-Gould, A; Pelletier, D	1
Ando, K; Mano, Y; Matsui, K; Mukoyama, M; Muramoto, O; Toyoshima, E	1
Cortes, J; Freireich, EJ; Gajewski, J; Giles, FJ; Kantarjian, HM; Koller, C; Kornblau, S; O'Brien, S; Rios, MB; Sacchi, S; Talpaz, M	1
Marsot Dupuch, K; Yeshurun, M	1
Shimizu, M; Yamamoto, M	1
Bradstock, K; Castaldi, P; Gottlieb, D; Koutts, J; Lee, C; Robertson, T	1
Matsui, K	1
Dworkin, LA; Fuchs, PC; Goldman, RD; Zivin, LS	1
Bazely, P; Braude, AI; Fierer, J	1

Trials

1 trial(s) available for cytarabine and Ataxia

Article	Year
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia. Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Female; Femur Head Necrosis; Humans; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Life Tables; Male; Middle Aged; Paranoid Disorders; Pilot Projects; Pseudotumor Cerebri; Pulmonary Edema; Red-Cell Aplasia, Pure; Remission Induction; Survival Analysis; Syncope; Treatment Outcome; Tretinoin	1999

Article

Year

Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.

Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6

Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Female; Femur Head Necrosis; Humans; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Life Tables; Male; Middle Aged; Paranoid Disorders; Pilot Projects; Pseudotumor Cerebri; Pulmonary Edema; Red-Cell Aplasia, Pure; Remission Induction; Survival Analysis; Syncope; Treatment Outcome; Tretinoin

1999

Other Studies

12 other study(ies) available for cytarabine and Ataxia

Article	Year
Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission. Clinical and experimental pharmacology & physiology, 2022, Volume: 49, Issue:9 Topics: Acetylcholine; Animals; Ataxia; Cytarabine; Dopamine; Female; Male; Mice; Oxazolidinones; Pyrrolidines; Rats; Spinocerebellar Degenerations; Synaptic Transmission; Thyrotropin-Releasing Hormone	2022
Pelvic axis-based gait analysis for ataxic mice. Journal of neuroscience methods, 2013, Sep-30, Volume: 219, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antimetabolites, Antineoplastic; Ataxia; Biomechanical Phenomena; Cytarabine; Diet; Dopamine Agents; Gait; Hindlimb; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Pelvis; Video Recording	2013
A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment. American journal of hematology, 2009, Volume: 84, Issue:10 Topics: Antineoplastic Agents; Aphasia; Ataxia; Benzamides; Blast Crisis; Confusion; Cytarabine; Diagnosis, Differential; Hearing Loss; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Stem Cell Transplantation; Treatment Outcome	2009
Induction of striatal neurogenesis enhances functional recovery in an adult animal model of neonatal hypoxic-ischemic brain injury. Neuroscience, 2010, Aug-11, Volume: 169, Issue:1 Topics: Animals; Ataxia; Brain Damage, Chronic; Brain-Derived Neurotrophic Factor; Carotid Arteries; Cerebral Palsy; Corpus Striatum; Cytarabine; Disease Models, Animal; Drug Evaluation, Preclinical; Epidermal Growth Factor; Forelimb; Hemiplegia; Hypoxia; Hypoxia-Ischemia, Brain; Infusions, Intraventricular; Ligation; Mice; Mice, Inbred ICR; Neurogenesis; Random Allocation; Recovery of Function	2010
Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. The New England journal of medicine, 2005, Jul-28, Volume: 353, Issue:4 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Aphasia; Ataxia; Brain; Cytarabine; Humans; Integrin alpha4; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Opportunistic Infections; Paresis	2005
[Studies on the behavioral pharmacology of TRH-T in cytosine arabinoside-induced ataxic mice: a comparison with genetically ataxic mice]. Jikken dobutsu. Experimental animals, 1983, Volume: 32, Issue:1 Topics: Age Factors; Animals; Ataxia; Cerebellum; Cytarabine; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; Motor Activity; Thyrotropin-Releasing Hormone	1983
Acute cerebellar syndrome following intermediate-dose cytarabine. British journal of haematology, 2001, Volume: 113, Issue:4 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Brain; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Dysarthria; Gait Ataxia; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Nystagmus, Pathologic; Prednisone; Syndrome; Vincristine	2001
Effect of YM-14673, a new thyrotropin releasing hormone analogue, on ataxic gait in cytosine arabinoside-treated mice. European journal of pharmacology, 1989, Aug-03, Volume: 166, Issue:3 Topics: Animals; Animals, Newborn; Ataxia; Azetidines; Azetines; Cytarabine; Dipeptides; Gait; Male; Mice; Mice, Inbred ICR; Motor Activity; Thyrotropin-Releasing Hormone	1989
The neurotoxicity of high-dose cytosine arabinoside is age-related. Cancer, 1987, Oct-01, Volume: 60, Issue:7 Topics: Activities of Daily Living; Adolescent; Adult; Age Factors; Ataxia; Brain; Cerebellum; Coma; Confusion; Cytarabine; Dysarthria; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Sleep Stages	1987
[Changes of ataxia, spontaneous movement and the cerebellar noradrenaline system with aging in ataxic mice]. Jikken dobutsu. Experimental animals, 1986, Volume: 35, Issue:1 Topics: Aging; Animals; Ataxia; Cerebellum; Cytarabine; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C3H; Motor Activity; Norepinephrine; Organ Size	1986
Cerebellar toxicity following high-dose cytosine arabinoside. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:5 Topics: Ataxia; Cerebellar Diseases; Cytarabine; Dysarthria; Humans; Leukemia; Male; Middle Aged; Purkinje Cells	1985
Herpes B virus encephalomyelitis presenting as ophthalmic zoster. A possible latent infection reactivated. Annals of internal medicine, 1973, Volume: 79, Issue:2 Topics: Animals; Antibodies; Aphasia; Ataxia; Cerebrospinal Fluid Proteins; Cytarabine; Diagnosis, Differential; Encephalomyelitis; gamma-Globulins; Haplorhini; Herpes Zoster Ophthalmicus; Herpesviridae Infections; Herpesvirus 1, Cercopithecine; Humans; Laboratory Infection; Male; Middle Aged; Muscle Tonus; Ophthalmic Nerve; Paresis; Prednisone; Skin; Time Factors	1973